Please select your view


Prenatal Screening for 22q11.2 Microdeletion

Introducing our Educational Modules

Watch our educational video presented by Chemical Pathologist, Associate Professor Mirette Saad. The video is 17 minutes in duration and discusses Prenatal Screening for 22q11.2 Microdeletion.

Prenatal Screening for 22q11.2 Microdeletion

About Associate Professor Mirette Saad

Associate Professor Mirette Saad is a Consultant Chemical Pathologist and the National Clinical Director of Molecular Genetic Pathology at Australian Clinical Labs. Associate Professor Mirette Saad’s PhD research allowed her to gain unique experience in a wide range of biochemical, molecular genetics and cancer targeting. At Clinical Labs, Associate Professor Saad leads the antenatal screening program including combined First Trimester Screening and Non-Invasive Prenatal Testing (NIPT) along with the Molecular Genetic testing for hereditary disorders, personalised drug therapy somatic mutation and gene expression profile testing in cancer.